Search fresh public links, source activity, and ready-to-use post angles for Regulatory....
Fresh curated links around Regulatory... are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
UK Regulatory Affairs and Pharmacovigilance: A Practical Guide to Compliance, Market Access and Product Lifecycle ManagementThe UK regulatory environment continues to evolve, creat...
Regulatory Affairs and Pharmacovigilance in Canada: A Lifecycle Approach for Pharma and Medical Device CompaniesIntroductionFor pharmaceutical and medical device companies entering...
The companies that emerge from this evolving regulatory cycle with clean, rigorous, globally positioned programs will find themselves in a structurally superior competitive positio...
Regulatory Affairs and Pharmacovigilance in India: A Lifecycle Approach for Pharma & Medical Device CompaniesIndia is a major pharmaceutical and medical device market, but succ...
Advances in technology are making it easier for biopharma companies to embrace continuous manufacturing. However, they are also changing what regulators expect from drug firms in t...
RNs will be issued by the MAA to notify changes in MAA owned process, or provide operational or engineering guidance.
Submission readiness extends beyond content. Early regulatory operations planning supports a compliant, high-quality application.
RIs will be issued by the MAA to provide direction, and have the same authority as MAA regulation.
Two topics of increasing regulatory scrutiny—the "Generally Recognized as Safe" (GRAS) rule and a federal definition of ultra-processed food (UPFs)—have seen some movement at the U...
In this virtual interview, context is given to how regulatory compliance has evolved along with its perception, to provide you with insights into how to approach your own efforts.
Midtier Life Sciences Companies Need to Rethink Their Regulatory Technology Strategy The hidden cost of complexity and customization Qual...
Welcome to the FinReg Monthly Update, a regular bulletin highlighting the latest developments in UK, EU and international financial services regulation. Key Developments in July 20...
Digital asset businesses rarely fit neatly within traditional legal categories
Hyman, Phelps & McNamara, P.C., the nation’s premier law firm dedicated exclusively to FDA and healthcare regulatory law, is seeking an experienced Medical Device Regulatory Ex...
Mid-Month Report – A monthly briefing on advertising enforcement actions with material implications for disclosure practices, litigation exposure, and reputational risk in collaber...
Regnology is moving into the next phase of its expansion, applying agentic artificial intelligence to the regulatory reporting, risk and finance capabilities assembled through its...
By Adrienne R. Lenz, Principal Medical Device Regulation Expert —
Operating a financial technology business across borders used to be a story of passporting. You sec...
This article discusses the regulatory aspects of food additives, along with how and why they are needed and developed.
Defence Medical Services Regulator (DMSR) will use one of two types of regulatory notification to allow timely communication of regulatory changes to DMSR regulatory documents. The...
The FDA says it can't license Regenative Lab's overseas sales today because it might change its regulations tomorrow. Now, the company is suing.
Gowrisankaran, Langer and Reguant have an excellent paper, Energy Transitions in Regulated Markets (WP), in the latest AER. The basic idea is that regulation designed to prevent ut...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.